Christopher H. Yaen

Array ( [id] => 7183217 [patent_doc_number] => 20040203060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'MDA-9 and uses thereof' [patent_app_type] => new [patent_app_number] => 10/843266 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25091 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20040203060.pdf [firstpage_image] =>[orig_patent_app_number] => 10843266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7183483 [patent_doc_number] => 20040203106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Signal peptide-containing molecules' [patent_app_type] => new [patent_app_number] => 10/839882 [patent_app_country] => US [patent_app_date] => 2004-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 29145 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20040203106.pdf [firstpage_image] =>[orig_patent_app_number] => 10839882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 366806 [patent_doc_number] => 07479543 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-20 [patent_title] => 'Reshaped human antibody to human interleukin-6 receptor' [patent_app_type] => utility [patent_app_number] => 10/837904 [patent_app_country] => US [patent_app_date] => 2004-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 25441 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/479/07479543.pdf [firstpage_image] =>[orig_patent_app_number] => 10837904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7348087 [patent_doc_number] => 20040248178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Beta netrin and uses thereof' [patent_app_type] => new [patent_app_number] => 10/831979 [patent_app_country] => US [patent_app_date] => 2004-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 49693 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248178.pdf [firstpage_image] =>[orig_patent_app_number] => 10831979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 141906 [patent_doc_number] => 07687465 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-30 [patent_title] => 'Therapeutic cancer vaccine' [patent_app_type] => utility [patent_app_number] => 10/553078 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 29344 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/687/07687465.pdf [firstpage_image] =>[orig_patent_app_number] => 10553078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7181197 [patent_doc_number] => 20040202648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Vaccines' [patent_app_type] => new [patent_app_number] => 10/816476 [patent_app_country] => US [patent_app_date] => 2004-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 33146 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20040202648.pdf [firstpage_image] =>[orig_patent_app_number] => 10816476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 334393 [patent_doc_number] => 07507805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'Cell death-inducing fused gene acting specifically on cancer and gene product thereof' [patent_app_type] => utility [patent_app_number] => 10/550280 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10470 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507805.pdf [firstpage_image] =>[orig_patent_app_number] => 10550280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7341319 [patent_doc_number] => 20040191218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Pharmaceutical compositions and methods for treating cancer' [patent_app_type] => new [patent_app_number] => 10/490791 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5437 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191218.pdf [firstpage_image] =>[orig_patent_app_number] => 10490791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 849280 [patent_doc_number] => 07381799 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-03 [patent_title] => 'Compositions and methods for inhibiting angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/806419 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 5259 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/381/07381799.pdf [firstpage_image] =>[orig_patent_app_number] => 10806419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7351239 [patent_doc_number] => 20040248799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Compositions and methods for treating cancer and hyperproliferative disorders' [patent_app_type] => new [patent_app_number] => 10/799163 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18129 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248799.pdf [firstpage_image] =>[orig_patent_app_number] => 10799163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314527 [patent_doc_number] => 07524495 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation' [patent_app_type] => utility [patent_app_number] => 10/546160 [patent_app_country] => US [patent_app_date] => 2004-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 9 [patent_no_of_words] => 7879 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524495.pdf [firstpage_image] =>[orig_patent_app_number] => 10546160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7336768 [patent_doc_number] => 20040132664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Antiangiogenic polypeptides and methods for inhibiting angiogenesis' [patent_app_type] => new [patent_app_number] => 10/778423 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10747 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132664.pdf [firstpage_image] =>[orig_patent_app_number] => 10778423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 334395 [patent_doc_number] => 07507807 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'TWEAK receptor' [patent_app_type] => utility [patent_app_number] => 10/754847 [patent_app_country] => US [patent_app_date] => 2004-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19448 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507807.pdf [firstpage_image] =>[orig_patent_app_number] => 10754847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7176103 [patent_doc_number] => 20050123537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Antibody conjugate methods for selectively inhibiting VEGF' [patent_app_type] => utility [patent_app_number] => 10/738404 [patent_app_country] => US [patent_app_date] => 2003-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 87800 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123537.pdf [firstpage_image] =>[orig_patent_app_number] => 10738404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7088535 [patent_doc_number] => 20050008647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Cancer metastasis interfering vaccine' [patent_app_type] => utility [patent_app_number] => 10/706406 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2500 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20050008647.pdf [firstpage_image] =>[orig_patent_app_number] => 10706406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7334880 [patent_doc_number] => 20040132119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Method for detecting gynecological cancers' [patent_app_type] => new [patent_app_number] => 10/686044 [patent_app_country] => US [patent_app_date] => 2003-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4418 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132119.pdf [firstpage_image] =>[orig_patent_app_number] => 10686044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7208706 [patent_doc_number] => 20050053607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Method for the diagnosis and prognosis of malignant diseases' [patent_app_type] => utility [patent_app_number] => 10/683480 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18652 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053607.pdf [firstpage_image] =>[orig_patent_app_number] => 10683480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7050756 [patent_doc_number] => 20050186643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Pin1 as a marker for abnormal cell growth' [patent_app_type] => utility [patent_app_number] => 10/683880 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25494 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20050186643.pdf [firstpage_image] =>[orig_patent_app_number] => 10683880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7168343 [patent_doc_number] => 20050202009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Novel MHC II associated peptides' [patent_app_type] => utility [patent_app_number] => 10/676675 [patent_app_country] => US [patent_app_date] => 2003-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14869 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20050202009.pdf [firstpage_image] =>[orig_patent_app_number] => 10676675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112239 [patent_doc_number] => 07718762 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Cancer vaccines containing epitopes of oncofetal antigen' [patent_app_type] => utility [patent_app_number] => 10/523277 [patent_app_country] => US [patent_app_date] => 2003-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21947 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718762.pdf [firstpage_image] =>[orig_patent_app_number] => 10523277 [rel_patent_id] =>[rel_patent_doc_number] =>)